The scientists working on the vaccine—which is seen as leading the race for a successful vaccine against COVID-19—are hoping for regulatory approval before 2021 begins.
The coronavirus pandemic has already claimed over a million lives across the globe.
Here are more details.
It is one of the biggest COVID-19 vaccine projects in the UK and has been made from a weakened, genetically-modified version of a common cold virus, or adenovirus, that causes infections in chimpanzees, but cannot grow in the human body.
Citing government scientists, The Times reported that a mass roll-out of a COVID-19 vaccine could be finished within three months.
A full COVID-19 immunization program, which would exclude children, could be quicker than experts predicted, The Times reported.
The report further stated that health officials estimate that every adult could receive a dose of the vaccine within six months.
Plans under consideration by the UK include a much wider group of healthcare staff to administer the vaccine, establishing drive-through vaccination centers, and recruiting members of the armed forces for assistance, The Times reported.
The European Medicines Agency said that it has started reviewing the vaccine in real-time. The move is aimed at accelerating any approval process for the vaccine in the region.
According to the Johns Hopkins University's tracker, COVID-19—which is caused by the coronavirus SARS-CoV-2—has affected 34.6 million people globally and killed over a million.
The United States is the worst-hit nation with 7.3 million infections and over 2 lakh deaths.
India is the second worst-hit, reporting 64,73,544 cases of COVID-19 and a death toll of 1,00,842, according to the Health Ministry's latest update.
Love World news?
Subscribe to stay updated.